Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Ipratropium Bromide Inhalation Solution in Acute Exacerbation of COPD
CTR20170768Phase 3Active
- Sponsor
- Sinolion Pharmaceutical
- Start
- Aug 2017
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Combivent in chronic obstructive pulmonary disease (COPD), sponsored by Sinolion Pharmaceutical. Started Aug 2017; status: active.
02
Drugs
Combivent
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20170768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170768.